| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A KLF4-DYRK2–mediated pathway regulating self-renewal in CML stem cells
|
Park, Chun Shik
|
|
|
134 |
22 |
p. 1960-1972
|
artikel
|
| 2 |
A role for macrophages in hematopoiesis in the embryonic head
|
Li, Zhuan
|
|
|
134 |
22 |
p. 1929-1940
|
artikel
|
| 3 |
Bai X, Zhang Y, Huang L, et al. The early activation of memory B cells from Wiskott-Aldrich syndrome patients is suppressed by CD19 downregulation. Blood. 2016;128(13):1723-1734.
|
|
|
|
134 |
22 |
p. 1997
|
artikel
|
| 4 |
Bioengineered iPSC-derived megakaryocytes for the detection of platelet-specific patient alloantibodies
|
Zhang, Nanyan
|
|
|
134 |
22 |
p. e1-e8
|
artikel
|
| 5 |
Cardiovascular adverse events of ibrutinib
|
Ahn, Inhye E.
|
|
|
134 |
22 |
p. 1881-1882
|
artikel
|
| 6 |
CLL: deep dive for residual cells by NGS matters
|
Wendtner, Clemens-Martin
|
|
|
134 |
22 |
p. 1883-1884
|
artikel
|
| 7 |
Donor cell engineering with GSK3 inhibitor–loaded nanoparticles enhances engraftment after in utero transplantation
|
Loukogeorgakis, Stavros P.
|
|
|
134 |
22 |
p. 1983-1995
|
artikel
|
| 8 |
Editorial Board
|
|
|
|
134 |
22 |
p. i
|
artikel
|
| 9 |
Engraftment in utero: it's all in the delivery
|
Abraham, Allistair A.
|
|
|
134 |
22 |
p. 1889-1890
|
artikel
|
| 10 |
Epigenetic therapies in acute myeloid leukemia: where to from here?
|
Fennell, Katie A.
|
|
|
134 |
22 |
p. 1891-1901
|
artikel
|
| 11 |
From Budd-Chiari syndrome to acquired von Willebrand syndrome: thrombosis and bleeding complications in the myeloproliferative neoplasms
|
Stein, Brady L.
|
|
|
134 |
22 |
p. 1902-1911
|
artikel
|
| 12 |
Hypertension and incident cardiovascular events following ibrutinib initiation
|
Dickerson, Tyler
|
|
|
134 |
22 |
p. 1919-1928
|
artikel
|
| 13 |
Infectious mononucleosis affecting sinonasal mucosa
|
Vali Betts, Elham
|
|
|
134 |
22 |
p. 1996
|
artikel
|
| 14 |
Killing the minotaur in its amazing maze
|
Krause, Daniela S.
|
|
|
134 |
22 |
p. 1884-1885
|
artikel
|
| 15 |
Minimal residual disease undetectable by next-generation sequencing predicts improved outcome in CLL after chemoimmunotherapy
|
Thompson, Philip A.
|
|
|
134 |
22 |
p. 1951-1959
|
artikel
|
| 16 |
Platelet alloantibody detection: moving ahead
|
Wilkie, Adrian R.
|
|
|
134 |
22 |
p. 1887-1888
|
artikel
|
| 17 |
Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin
|
Suzuki-Inoue, Katsue
|
|
|
134 |
22 |
p. 1912-1918
|
artikel
|
| 18 |
Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: phase 2 trial results
|
Shapiro, Amy D.
|
|
|
134 |
22 |
p. 1973-1982
|
artikel
|
| 19 |
TFPI blockade: removing coagulation's brakes
|
Sidonio Jr, Robert F.
|
|
|
134 |
22 |
p. 1885-1887
|
artikel
|
| 20 |
The architecture of the IgG anti-carbohydrate repertoire in primary antibody deficiencies
|
Jandus, Peter
|
|
|
134 |
22 |
p. 1941-1950
|
artikel
|
Tijdschrift beschrijving